Mark Broadwin (M Broadwin)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 22

Top Topics

Cardiac Resynchronization Therapy

Systematic Review

Extracellular Matrix

Top Venues

Medical sciences (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Khaled Hamsho, Mark Broadwin, Christopher R Stone, Frank W Sellke, M Ruhul Abid
The Current State of Extracellular Matrix Therapy for Ischemic Heart Disease. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Khaled Hamsho, Mark Broadwin, Christopher R Stone, Frank W Sellke, M Ruhul Abid
The Current State of Extracellular Matrix Therapy for Ischemic Heart Disease. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Maryam Ateeq, Mark Broadwin, Frank W Sellke, M Ruhul Abid
Extracellular Vesicles' Role in Angiogenesis and Altering Angiogenic Signaling. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Khaled Hamsho, Mark Broadwin, Christopher R Stone, Frank W Sellke, M Ruhul Abid
The Current State of Extracellular Matrix Therapy for Ischemic Heart Disease. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Khaled Hamsho, Mark Broadwin, Christopher R Stone, Frank W Sellke, M Ruhul Abid
The Current State of Extracellular Matrix Therapy for Ischemic Heart Disease. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Dwight D Harris, Sharif A Sabe, Mark Broadwin, Christopher Stone, Cynthia Xu, Jiayu Hu, Meghamsh Kanuparthy, M Ruhul Abid, Frank W Sellke
Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia. Biomedicines 12 (3) (2024)
Khaled Hamsho, Mark Broadwin, Christopher R Stone, Frank W Sellke, M Ruhul Abid
The Current State of Extracellular Matrix Therapy for Ischemic Heart Disease. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Maryam Ateeq, Mark Broadwin, Frank W Sellke, M Ruhul Abid
Extracellular Vesicles' Role in Angiogenesis and Altering Angiogenic Signaling. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Maryam Ateeq, Mark Broadwin, Frank W Sellke, M Ruhul Abid
Extracellular Vesicles' Role in Angiogenesis and Altering Angiogenic Signaling. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Dwight D Harris, Sharif A Sabe, Mark Broadwin, Christopher Stone, Cynthia Xu, Jiayu Hu, Meghamsh Kanuparthy, M Ruhul Abid, Frank W Sellke
Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia. Biomedicines 12 (3) (2024)
Maryam Ateeq, Mark Broadwin, Frank W Sellke, M Ruhul Abid
Extracellular Vesicles' Role in Angiogenesis and Altering Angiogenic Signaling. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Maryam Ateeq, Mark Broadwin, Frank W Sellke, M Ruhul Abid
Extracellular Vesicles' Role in Angiogenesis and Altering Angiogenic Signaling. Medical sciences (Basel, Switzerland) 12 (1) (2024)
Christopher R Stone, Dwight D Harris, Mark Broadwin, Meghamsh Kanuparthy, Ju-Woo Nho, Keertana Yalamanchili, Jad Hamze, M Ruhul Abid, Frank W Sellke
Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease. bioRxiv : the preprint server for biology (2024)
Cynthia M Xu, Mark Broadwin, Patrick Faherty, Rayane Brinck Teixeira, Mohamed Sabra, Frank W Sellke, M Ruhul Abid
Lack of cardiac benefit after intramyocardial or intravenous injection of mesenchymal stem cell-derived extracellular vesicles supports the need for optimized cardiac delivery. Vessel plus 7 (2023)
Sharif A Sabe, Cynthia M Xu, Brittany A Potz, Akshay Malhotra, Mohamed Sabra, Dwight D Harris, Mark Broadwin, M Ruhul Abid, Frank W Sellke
Comparative Analysis of Normoxia- and Hypoxia-Modified Extracellular Vesicle Therapy in Function, Perfusion, and Collateralization in Chronically Ischemic Myocardium. International journal of molecular sciences 24 (3) (2023)
Mark Broadwin, N Ramkumar, D J Malenka, R D Quinn, C S Ross, F Hirashima, J D Klemperer, R S Kramer, G L Sardella, B Westbrook, A W Discipio, A Iribarne, M P Robich
Long-Term Outcomes of Bovine versus Porcine Mitral Valve Replacement: A Multicenter Analysis. Cardiology research and practice 2023 (2023)
Cynthia M Xu, Mark Broadwin, Patrick Faherty, Rayane Brinck Teixeira, Mohamed Sabra, Frank W Sellke, M Ruhul Abid
Lack of cardiac benefit after intramyocardial or intravenous injection of mesenchymal stem cell-derived extracellular vesicles supports the need for optimized cardiac delivery. Vessel plus 7 (2023)
Sharif A Sabe, Dwight Douglas Harris, Mark Broadwin, Mohamed Sabra, Cynthia M Xu, Debolina Banerjee, M Ruhul Abid, Frank W Sellke
Sitagliptin therapy improves myocardial perfusion and arteriolar collateralization in chronically ischemic myocardium: A pilot study. Physiological reports 11 (11) (2023)
Cynthia M Xu, Mark Broadwin, Patrick Faherty, Rayane Brinck Teixeira, Mohamed Sabra, Frank W Sellke, M Ruhul Abid
Lack of cardiac benefit after intramyocardial or intravenous injection of mesenchymal stem cell-derived extracellular vesicles supports the need for optimized cardiac delivery. Vessel plus 7 (2023)
Sharif A Sabe, Cynthia M Xu, Brittany A Potz, Akshay Malhotra, Mohamed Sabra, Dwight D Harris, Mark Broadwin, M Ruhul Abid, Frank W Sellke
Comparative Analysis of Normoxia- and Hypoxia-Modified Extracellular Vesicle Therapy in Function, Perfusion, and Collateralization in Chronically Ischemic Myocardium. International journal of molecular sciences 24 (3) (2023)
Sharif A Sabe, Cynthia M Xu, Brittany A Potz, Akshay Malhotra, Mohamed Sabra, Dwight D Harris, Mark Broadwin, M Ruhul Abid, Frank W Sellke
Comparative Analysis of Normoxia- and Hypoxia-Modified Extracellular Vesicle Therapy in Function, Perfusion, and Collateralization in Chronically Ischemic Myocardium. International journal of molecular sciences 24 (3) (2023)
Sharif A Sabe, Cynthia M Xu, Brittany A Potz, Akshay Malhotra, Mohamed Sabra, Dwight D Harris, Mark Broadwin, M Ruhul Abid, Frank W Sellke
Comparative Analysis of Normoxia- and Hypoxia-Modified Extracellular Vesicle Therapy in Function, Perfusion, and Collateralization in Chronically Ischemic Myocardium. International journal of molecular sciences 24 (3) (2023)